Skip to main content

MoneyWorks4Me

The revenue zoomed 18.51% to Rs. 1371.68 millions for the quarter ended September 2026 as compared to Rs. 1157.48 millions during the corresponding quarter last year.Handsome Net Profit growth of 87.17% reported above the corresponding previous quarter figure of Rs. 417.05 millions to Rs. 222.82 millions.Operating profit for the quarter ended September 2026 rose to 543.16 millions as compared to 326.70 millions of corresponding quarter ended September 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 1371.68 1157.48 18.51 2530.25 2407.72 5.09 4527.66 3514.11 28.84
Other Income 163.97 30.79 432.54 186.84 569.31 -67.18 633.88 614.90 3.09
PBIDT 543.16 326.70 66.26 870.15 1170.48 -25.66 1738.22 1321.69 31.51
Interest 0.31 0.49 -36.73 0.68 1.02 -33.33 2.07 2.36 -12.29
PBDT 542.85 326.21 66.41 869.47 1169.46 -25.65 1697.57 1319.33 28.67
Depreciation 31.73 30.02 5.70 60.94 59.31 2.75 120.83 114.05 5.94
PBT 511.12 296.19 72.56 808.53 1110.15 -27.17 1576.74 1205.28 30.82
TAX 94.07 73.37 28.21 168.02 147.52 13.90 258.68 181.08 42.85
Deferred Tax 1.25 0.54 131.48 8.56 0.28 2957.14 -12.01 12.22 -198.28
PAT 417.05 222.82 87.17 640.51 962.63 -33.46 1318.06 1024.20 28.69
Equity 220.53 223.76 -1.44 223.95 223.76 0.08 223.85 223.76 0.04
PBIDTM(%) 39.60 28.23 40.29 34.39 48.61 -29.26 38.39 37.61 2.07
Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..